NovaBridge Biosciences (NBP) Shareholders’ equity 2021–2025
NovaBridge Biosciences (NBP) shareholders’ equity at each fiscal year-end, per SEC filings.
$242.6MFY2025 · since FY2021: -$292.3M → $242.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $242.6M | -41.9% |
| FY2024 | $417.8M | -41.6% |
| FY2023 | $715.1M | -17.1% |
| FY2022 | $862.4M | +395.1% |
| FY2021 | -$292.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice